(Q44160575)

30 November 2017

title

Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects (English)

1 reference

30 November 2017

1 reference

1 reference

coronary artery disease

1 reference

1

Ernst J Schaefer

1 reference

30 November 2017

Judith R McNamara

2

1 reference

30 November 2017

Timothy Tayler

3

1 reference

30 November 2017

Jennifer A Daly

4

1 reference

30 November 2017

Joi A Gleason

5

1 reference

30 November 2017

Leo J Seman

6

1 reference

30 November 2017

Andrea Ferrari

7

1 reference

30 November 2017

Joel J Rubenstein

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

American Journal of Cardiology

30 November 2017

published in

1 reference

30 November 2017

volume

90

1 reference

30 November 2017

issue

7

1 reference

30 November 2017

page(s)

689-696

1 reference

Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Simvastatin treatment on postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Dietary restriction of saturated fat and cholesterol decreases HDL ApoA-I secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Effectiveness of high doses of simvastatin as monotherapy in mixed hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Effect of statin therapy on remnant lipoprotein cholesterol levels in patients with combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Effect of corn and coconut oil-containing diets with and without cholesterol on high density lipoprotein apoprotein A-I metabolism and hepatic apoprotein A-I mRNA levels in cebus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(02)02591-2

1 reference

30 November 2017

1 reference